(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-05 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 832050
| Date | Daily Closing Price | Open | High | Low | Volume |
| 05 Wed Feb 2025 | 110.37 | 113.55 | 115.77 | 110.17 | 1.405 times |
| 04 Tue Feb 2025 | 113.40 | 110.61 | 114.14 | 110.61 | 1.065 times |
| 03 Mon Feb 2025 | 111.50 | 109.20 | 112.70 | 109.06 | 0.91 times |
| 31 Fri Jan 2025 | 112.53 | 114.49 | 116.23 | 112.18 | 0.695 times |
| 30 Thu Jan 2025 | 114.05 | 115.00 | 116.00 | 112.73 | 1.561 times |
| 29 Wed Jan 2025 | 114.32 | 113.87 | 117.09 | 113.68 | 0.786 times |
| 28 Tue Jan 2025 | 114.47 | 114.41 | 115.35 | 113.40 | 0.516 times |
| 27 Mon Jan 2025 | 113.88 | 113.90 | 118.25 | 113.31 | 0.99 times |
| 24 Fri Jan 2025 | 114.91 | 114.75 | 117.48 | 114.64 | 0.842 times |
| 23 Thu Jan 2025 | 115.63 | 111.26 | 116.12 | 111.26 | 1.778 times |
My analysis of stock is bullish for shortterm, and stock might move up till 116.2 or till 125.3. Use a stoploss of 108.55 and if this stock hits its stoploss, then it can fall down till 100.95
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 80.68 |
| Downside Target | 85.91 |
| Downside Target | 90.23 |
| Downside Target | 94.98 |
| Downside Target | 98.41 |
| Downside Target | 103.55 |
| Downside Target | 108.16 |
| Upside Target | 112.18 |
| Upside Target | 115.77 |
| Upside Target | 117.48 |
| Upside Target | 118.25 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 107.7 |
| Downside Intraday Target | 105.02 |
| Upside Intraday Target | 114.41 |
| Upside Intraday Target | 118.44 |
| Upside Intraday Target | 111.73 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 05 Wed Feb 2025 | 110.37 | 109.20 | 115.77 | 109.06 | 0.743 times |
| 31 Fri Jan 2025 | 112.53 | 113.90 | 118.25 | 112.18 | 1.027 times |
| 24 Fri Jan 2025 | 114.91 | 110.24 | 117.48 | 108.16 | 3.792 times |
| 17 Fri Jan 2025 | 110.05 | 105.87 | 110.28 | 104.73 | 0.15 times |
| 17 Fri Jan 2025 | 110.05 | 90.29 | 110.28 | 90.23 | 2.903 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 05 Wed Feb 2025 | 110.37 | 109.20 | 115.77 | 109.06 | 0.139 times |
| 31 Fri Jan 2025 | 112.53 | 88.06 | 118.25 | 86.72 | 1.977 times |
| 31 Tue Dec 2024 | 87.22 | 96.29 | 98.41 | 85.91 | 0.829 times |
| 26 Tue Nov 2024 | 94.63 | 87.53 | 103.55 | 87.28 | 0.85 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 113.53 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 113.53 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.